Pharmacologic treatments for covid-19 patients
Methisoprinol vs Standard care
This comparison will not be updated. Last search date 14 Dec, 2022.
To access all information :
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=251
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| N/A Borges M, Revista Universidad,, 2021 Full text Commentary |
Not reported/unclear |
Methisoprinol |
Standard care |
RCT | Outpatients with confirmed COVID-19 (symptomatic) treated at home in Ecuador | N=60 | N/A | |